- Home
- LLY vs WFC Comparison
LLY vs WFC Comparison
Compare LLY & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$928.48
Company Overview
Basic Information| Metric | LLY | WFC |
|---|---|---|
| Founded | 1876 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 950.7B | 290.6B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | LLY | WFC |
|---|---|---|
| Price | $928.48 | $76.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 16 |
| Target Price | ★ $1,174.53 | $97.37 |
| AVG Volume (30 Days) | 2.1M | ★ 14.0M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | 0.72% | ★ 2.36% |
| EPS Growth | ★ 95.99 | N/A |
| EPS | ★ 22.95 | N/A |
| Revenue | ★ $65,179,000,000.00 | N/A |
| Revenue This Year | $27.04 | $11.46 |
| Revenue Next Year | $16.26 | $4.55 |
| P/E Ratio | $41.86 | ★ $14.15 |
| Revenue Growth | ★ 44.70 | N/A |
| 52 Week Low | $623.78 | $58.42 |
| 52 Week High | $1,133.95 | $97.76 |
Technical Indicators
Market Signals| Indicator | LLY | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 33.01 | 33.55 |
| Support Level | $766.48 | $71.95 |
| Resistance Level | $1,102.49 | $78.37 |
| Average True Range (ATR) | 25.93 | 2.35 |
| MACD | -5.47 | -0.53 |
| Stochastic Oscillator | 1.65 | 16.86 |
Price Performance
Historical Comparison LLY
WFC
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.1 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.